Cargando…

HDL as a drug and nucleic acid delivery vehicle

This review is intended to evaluate the research findings and potential clinical applications of drug transport systems, developed based on the concepts of the structure/function and physiological role(s) of high density lipoprotein type nanoparticles. These macromolecules provide targeted transport...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lacko, Andras G., Sabnis, Nirupama A., Nagarajan, Bhavani, McConathy, Walter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620406/ https://www.ncbi.nlm.nih.gov/pubmed/26578957 http://dx.doi.org/10.3389/fphar.2015.00247

Ejemplares similares

The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics
por: Cruz, Pedro M. R., et al.
Publicado: (2013)

Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
por: Raut, Sangram, et al.
Publicado: (2018)

The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
por: Johnson, Rebecca, et al.
Publicado: (2013)

Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles
por: Sabnis, Nirupama, et al.
Publicado: (2012)

Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
por: Mooberry, Linda K., et al.
Publicado: (2016)

Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery
por: Sabnis, Sarika, et al.
Publicado: (2017)

Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma
por: Sabnis, Nirupama, et al.
Publicado: (2013)

Ultrasound-Stimulated Drug Delivery Using Therapeutic Reconstituted High-Density Lipoprotein Nanoparticles
por: Xiong, Fangyuan, et al.
Publicado: (2017)

Abnormal Glucose Metabolism in Hispanic Parents of Children with Acanthosis Nigricans
por: Urrutia-Rojas, Ximena, et al.
Publicado: (2011)

Editorial: Stem Cells as Targeted Drug Delivery Vehicles
por: Kusuma, Gina D., et al.
Publicado: (2020)

SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer
por: Johnson, Rebecca, et al.
Publicado: (2017)

An Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery Vehicles
por: Gangadaran, Prakash, et al.
Publicado: (2018)

Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment
por: Harrison, Emily B., et al.
Publicado: (2018)

Nucleic Acids Delivery Into the Cells Using Pro-Apoptotic Protein Lactaptin
por: Chinak, Olga, et al.
Publicado: (2019)

Targeted Nanoparticles for Pediatric Leukemia Therapy
por: Basha, Riyaz, et al.
Publicado: (2014)

Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers
por: Durymanov, Mikhail, et al.
Publicado: (2018)

The SR-B1 Receptor as a Potential Target for Treating Glioblastoma
por: Berney, Ethan, et al.
Publicado: (2019)

Platinum Nanoparticles in Biomedicine: Preparation, Anti-Cancer Activity, and Drug Delivery Vehicles
por: Abed, Atena, et al.
Publicado: (2022)

Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery route
por: Chen, Fengqian, et al.
Publicado: (2022)

Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders
por: Shah, Pranav, et al.
Publicado: (2022)

Identification of Docetaxel as a Potential Drug to Promote HDL Biogenesis
por: Choi, Hong Y., et al.
Publicado: (2021)

Trends and Hotspots in Nanoparticles for the Targeted Delivery of Nucleic Acids: A Ten-Year Bibliometric Study
por: Huang, Yingzhao, et al.
Publicado: (2022)

Antioxidant properties of HDL
por: Soran, Handrean, et al.
Publicado: (2015)

Role of PET imaging for biochemical recurrence following primary treatment for prostate cancer
por: Galgano, Samuel J., et al.
Publicado: (2018)

Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery
por: Grijalvo, Santiago, et al.
Publicado: (2019)

HDL in sepsis – risk factor and therapeutic approach
por: Morin, Emily E., et al.
Publicado: (2015)

Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges
por: Du, Rong, et al.
Publicado: (2022)

HDL particle number and size as predictors of cardiovascular disease
por: Kontush, Anatol
Publicado: (2015)

HDL and glucose metabolism: current evidence and therapeutic potential
por: Siebel, Andrew L., et al.
Publicado: (2015)

Protective Effects of HDL Against Ischemia/Reperfusion Injury
por: Gomaraschi, Monica, et al.
Publicado: (2016)

Use of Submicron Vaterite Particles Serves as an Effective Delivery Vehicle to the Respiratory Portion of the Lung
por: Gusliakova, Olga, et al.
Publicado: (2018)

Delivery of Nucleic Acids
por: Mastrobattista, Enrico, et al.
Publicado: (2007)

Nucleic Acid Delivery
por: Lu, Zheng-Rong, et al.
Publicado: (2023)

Delivery Systems for In Vivo Use of Nucleic Acid Drugs
por: Resende, R.R, et al.
Publicado: (2007)

Precision spherical nucleic acids for delivery of anticancer drugs
por: Bousmail, Danny, et al.
Publicado: (2017)

Pharmacological Intervention to Modulate HDL: What Do We Target?
por: Woudberg, Nicholas J., et al.
Publicado: (2018)

Dual Viscosity Mixture Vehicle for Intratympanic Dexamethasone Delivery Can Block Ototoxic Hearing Loss
por: Li, Hui, et al.
Publicado: (2021)

An optimized live bacterial delivery vehicle safely and efficaciously delivers bacterially transcribed therapeutic nucleic acids
por: Mora, Darcy S. O., et al.
Publicado: (2023)

Co-Delivery of p53 Restored and E7 Targeted Nucleic Acids by Poly (Beta-Amino Ester) Complex Nanoparticles for the Treatment of HPV Related Cervical Lesions
por: Xiong, Jinfeng, et al.
Publicado: (2022)

Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
por: Morin, Emily E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q6ter1gq9ok2pk76dbee5ml011